| pubmed-article:15061675 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C0032285 | lld:lifeskim |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C0521346 | lld:lifeskim |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C1504389 | lld:lifeskim |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C0672596 | lld:lifeskim |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C0149783 | lld:lifeskim |
| pubmed-article:15061675 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:15061675 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15061675 | pubmed:dateCreated | 2004-4-5 | lld:pubmed |
| pubmed-article:15061675 | pubmed:abstractText | A case is reported of a 56-y-old woman with a second relapse of Hodgkin's disease who early developed after autologous stem cell transplantation (ASCT) a severe RSV-related interstitial pneumonia successfully treated with 1-d intravenous palivizumab 8 mg/kg plus low-dose systemic steroid therapy. B-cells suppression with CMV antigenaemia were then observed and required treatment with ganciclovir and liposomal amfotericine B. | lld:pubmed |
| pubmed-article:15061675 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15061675 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15061675 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15061675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15061675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15061675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15061675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15061675 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15061675 | pubmed:issn | 0036-5548 | lld:pubmed |
| pubmed-article:15061675 | pubmed:author | pubmed-author:CattelanAnna... | lld:pubmed |
| pubmed-article:15061675 | pubmed:author | pubmed-author:MonfardiniSil... | lld:pubmed |
| pubmed-article:15061675 | pubmed:author | pubmed-author:CrivellariGin... | lld:pubmed |
| pubmed-article:15061675 | pubmed:author | pubmed-author:BannaGiuseppe... | lld:pubmed |
| pubmed-article:15061675 | pubmed:author | pubmed-author:AversaSavina... | lld:pubmed |
| pubmed-article:15061675 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15061675 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:15061675 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15061675 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15061675 | pubmed:pagination | 155-7 | lld:pubmed |
| pubmed-article:15061675 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:meshHeading | pubmed-meshheading:15061675... | lld:pubmed |
| pubmed-article:15061675 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15061675 | pubmed:articleTitle | Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy. | lld:pubmed |
| pubmed-article:15061675 | pubmed:affiliation | Medical Oncology, University Hospital of Padova, Padova, Italy. gbanna@yahoo.com | lld:pubmed |
| pubmed-article:15061675 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15061675 | pubmed:publicationType | Case Reports | lld:pubmed |
